Key facts
- This page summarizes William DeVaul's Form 4 filing for Morphic Holding, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Jul 2024, 17:32.
William DeVaul - 08 Jul 2024 Form 4 Insider Report for Morphic Holding, Inc.
- Reporting relationship
- General Counsel and Secretary
- Issuer ticker
- N/A
- Reported as of
- 08 Jul 2024
- Net transaction value
- -$514,756
- SEC form
- 4
- Accepted by SEC
- 10 Jul 2024, 17:32:17 UTC
- Prior SEC filing
- 17 Jan 2024
- Next SEC filing
- 07 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Farrell, Attorney-in-Fact for William DeVaul
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William DeVaul filed Form 4 for Morphic Holding, Inc. on 10 Jul 2024.
Change
- Previous filing in this sequence was filed on 17 Jan 2024.
- Current net transaction value: -$514,756.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MORF
transaction
Common Stock
Options Exercise
- Transaction value
- $43,151
- Shares
- +10,000
- Change %
- +43%
- Price
- $4.32
- Shares after
- 33,029
- Date
- 08 Jul 2024
- Ownership
- Direct
MORF
transaction
Common Stock
Sale
- Transaction value
- $557,907
- Shares
- -10,000
- Change %
- -30%
- Price
- $55.79
- Shares after
- 23,029
- Date
- 08 Jul 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MORF
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -8.8%
- Price
- $0.000000
- Shares after
- 103,855
- Date
- 08 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $4.32
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2023.
Footnote F2
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $55.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The option is fully vested.